Angelini Chemicals

News & publications

  1. CDMO - CRDMO: tools and different business model for new opportunity in synthesis

    The active pharmaceutical ingredient (API) is the foundation of a final drug product and is a crucial consideration when choosing a Contract Development and Manufacturing Organisation (CDMO) or Contract Research (in House) Development and Manufacturing Organisation (CRDMO).

  2. CFRT

    CFRT is the prime international event to learn about the latest innovation and technologies related to the field of flow chemistry and continuous manufacturing.

Who we are

Our services

R&D

  1. API expertise

    Angelini’s strength in API Research & Development is proven by being the partner of choice for large pharma and smaller biotech companies seeking integrated drug development solutions to accelerate R&D pipelines from bench to market.

  2. Kilo-lab

    Angelini R&D team can rapidly develop scalable, robust and cost-effective chemical synthesis that can be readily transferred to our kilo-labs either as a proof of concept study, or for scale-up and delivery of material to support your early clinical supply as well as small volume API and HPAPI.